Funded Biotechnology Startups in Cincinnati
Cincinnati's biotechnology sector has generated rounds ranging from $2M to $225M across this dataset of 10 companies, spanning mid-2021 through mid-2025.
Cincinnati's biotechnology sector has generated rounds ranging from $2M to $225M across this dataset of 10 companies, spanning mid-2021 through mid-2025. The two largest raises came in 2022: CinCor Pharma pulled in $225M via Post-IPO Equity in August, and Enable Injections closed a $215M Series C in January of that year, signaling that the market can support substantial late-stage and post-public capital formation.
Activity was notably dense in 2024, with four rounds closing between January and October — Onconetix ($27M), Alphyn Biologics ($5M), Cordata Healthcare Innovations ($2M), and Sus Clinicals ($4M, the only explicitly seed-stage entry in the set). The majority of rounds carry a "Series Unknown" designation, reflecting undisclosed or non-standard structures. The most recent disclosed round belongs to Eikonoklastes Therapeutics, which raised $14M in July 2025.
Most recent rounds
10 shownRelated listings
Frequently asked
What are the largest funding rounds among Cincinnati biotech companies in this dataset?
The two standout raises are CinCor Pharma's $225M Post-IPO Equity round in August 2022 and Enable Injections' $215M Series C in January 2022. After those, the next largest is Onconetix at $27M, raised in October 2024.
Which round stages appear most often for Cincinnati biotech companies here?
The majority of rounds are listed as "Series Unknown," reflecting undisclosed or non-standard structures. Named stage exceptions include one Seed round (Sus Clinicals, $4M), one Series C (Enable Injections, $215M), and two Post-IPO Equity rounds (CinCor Pharma and Blue Water Vaccines).
How has Cincinnati biotech funding activity trended across this time span?
The largest capital concentration came in early 2022, when Enable Injections and CinCor Pharma together raised $440M. Activity then shifted to smaller, more frequent rounds through 2023 and 2024, with four separate closings in 2024 alone and a $14M round by Eikonoklastes Therapeutics recorded in July 2025.
Which companies in this dataset had already gone public before their listed round?
Two companies raised Post-IPO Equity: CinCor Pharma ($225M, August 2022) and Blue Water Vaccines ($8M, April 2022), both indicating they had completed an IPO prior to these capital raises.
What does the funding range look like for the smaller raises in this Cincinnati biotech set?
Setting aside the two large 2022 outliers, round sizes span from $2M (Cordata Healthcare Innovations, September 2024) to $27M (Onconetix, October 2024), with most remaining raises clustering between $3M and $15M.
Which Cincinnati biotech company has the most recent funding event in this dataset?
Eikonoklastes Therapeutics holds the most recent entry, having raised $14M in a Series Unknown round dated July 27, 2025.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.